Bata India Announces 93rd AGM on Aug 12, 2026; Releases Annual Report FY26
Bata India Limited will hold its 93rd AGM on August 12, 2026. The company reported FY26 sales of ₹35,155 Million and profit after tax of ₹1,336 Million. A dividend of ₹9 per equity share is recommended. Gunjan Shah will conclude his tenure as MD & CEO on September 30, 2026, succeeded by Sanjay S. Rao.
The AGM announcement and release of the annual report are important for shareholders and stakeholders as they provide financial performance details and future strategic direction. The change in MD & CEO also has a medium-term impact on the company's leadership.
The announcement is primarily a notice of the AGM and release of the annual report, which is a routine corporate event. While financial performance is mentioned, there are no significant positive or negative surprises that would warrant a strong sentiment.
Bata India Limited has announced its 93rd Annual General Meeting (AGM) will be held on Wednesday, August 12, 2026, at 11:30 AM IST through Video Conferencing or Other Audio Visual Means. The company has also released its Annual Report for the Financial Year ended March 31, 2026.
The notice of the AGM, which forms part of the Annual Report, is being sent via email to shareholders. For shareholders whose email addresses are not registered, a letter is being sent providing a web-link to access the complete Annual Report.
The Annual Report for FY 2025-26 highlights a sales turnover of ₹35,155 Million and EBITDA of ₹7,063 Million. Profits after tax stood at ₹1,336 Million for FY 2025-26, after accounting for VRS costs and non-cash forex loss. The company also recommended a dividend of ₹9 per equity share for FY 2025-26.
The report details the company's strategic initiatives, including the 'Reignite' strategy focusing on product excellence and marketing, as well as operational efficiency improvements in manufacturing, sourcing, and supply chain. It also mentions the upcoming transition of MD & CEO Gunjan Shah on September 30, 2026, and the appointment of Sanjay S. Rao as the new MD & CEO.
What to do with a filing like this
Bata India Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bata India Limited. Read the original for the full detail.